A new era for treatment development in HER2-positive breast cancer.
Fiche publication
Date publication
février 2018
Journal
The Lancet. Oncology
Lien Pubmed
Mots clés
Antibodies, Monoclonal, Humanized, Breast Neoplasms, Fulvestrant, Humans, Neoadjuvant Therapy, Piperazines, Pyridines, Trastuzumab
Référence
Lancet Oncol.. 2018 Feb;19(2):160-162